Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | IL-6 | 100 | ug/mL | 3 | SCGF-b | 81.5 | 52 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | SCGF-b | 58.5 | 54 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCGF-b | 63.0 | 40 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCGF-b | 59.5 | 68 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | SCGF-b | 73.5 | 56 | |
| N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | SCGF-b | 72.0 | 60 | |
| N2586 | Sigma A6730 | 3.0 | uM | 3 | SCGF-b | 90.0 | 50 | ||||
| RA2159 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 66.0 | 64 | ||||
| RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 68.5 | 42 | |
| RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 79.0 | 83 | |
| RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 77.0 | 73 | |
| RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 71.5 | 68 | |
| RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 64.5 | 48 | |
| RA2159 | PI103 | 0.1 | uM | 3 | SCGF-b | 58.5 | 56 | ||||
| N2586 | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 68.5 | 54 | ||||
| N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 57.5 | 64 | |
| N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 60.0 | 69 | |
| N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 77.5 | 48 | |
| N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 76.0 | 53 | |
| N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | SCGF-b | 67.5 | 50 | |
| N2586 | PI103 | 0.1 | uM | 3 | SCGF-b | 69.0 | 55 | ||||
| 0 | SCGF-b | 45.5 | 58 | ||||||||
| RA2159 | TNF-a | 100 | ng/mL | 3 | SCGF-b | 97.0 | 51 | ||||
| RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 76.0 | 61 | |
| RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | SCGF-b | 72.0 | 74 |